Skip to main content

Caterina Fernàndez Garberi

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Caterina Fernàndez Garberi

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Gerard García Rodríguez

Gerard García Rodríguez

Main researcher
Physical Medicine and Rehabilitation
Read more
Antonio Álvarez Fernandez

Antonio Álvarez Fernandez

Main researcher
Pneumology
Read more
Júlia Oliver Hernando

Júlia Oliver Hernando

Research technician
Headache and Neurological Pain
Read more
Angeles Rojas Lopez

Angeles Rojas Lopez

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.